Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Monitoring Airborne Particulates in Production Areas – V 2.0

Posted on By

Creams: SOP for Monitoring Airborne Particulates in Production Areas – V 2.0

Standard Operating Procedure for Monitoring Airborne Particulates in Production Areas

Department Creams
SOP No. SOP/CRM/173/2025
Supersedes SOP/CRM/173/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for monitoring airborne particulates in the production areas during cream manufacturing. This is essential to ensure a clean and controlled environment, preventing contamination of cream products and ensuring compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to the monitoring of airborne particulates in all production areas where cream manufacturing takes place. It covers the use of air monitoring equipment, inspection processes, and corrective actions in case particulate levels exceed acceptable limits.

3. Responsibilities

  • Production Team: Responsible for ensuring that the production areas are maintained as per cleanliness standards and assisting in monitoring airborne particulates during production.
  • Quality Control (QC) Team: Responsible for monitoring airborne particulates in the production area, performing tests, and ensuring that particulate levels are within acceptable limits. QC also ensures that any required corrective actions are taken.
  • Maintenance Team: Responsible for ensuring that all air filtration and ventilation equipment is functioning properly
to minimize airborne particulates in production areas.
  • Laboratory Supervisor: Responsible for overseeing the particulate monitoring process, reviewing data, and ensuring that corrective actions are documented and implemented as required.
  • 4. Accountability

    The Production Manager is accountable for ensuring that the monitoring of airborne particulates is carried out as per this SOP. The QC Manager is responsible for overseeing the testing and corrective actions if particulate levels exceed the acceptable range. The Laboratory Supervisor is accountable for reviewing and ensuring that the necessary actions are taken in case of deviations.

    5. Procedure

    5.1 Pre-Monitoring Setup

    1. Ensure that all air monitoring equipment, including particulate counters and air samplers, are calibrated and functional before use. Calibration should be performed according to the manufacturer’s specifications and at regular intervals.
    2. Verify that the production area is prepared and clean, with all ventilation systems and air filters in place to minimize particulate contamination during production.
    3. Ensure that the monitoring points for airborne particulates are selected in critical production areas, such as near open containers, filling lines, and areas where product contact occurs.
    4. Verify that operators are trained to understand the significance of airborne particulates and the methods for maintaining clean room environments.

    5.2 Monitoring Airborne Particulates

    1. At the beginning of each production run, initiate real-time monitoring of airborne particulates using calibrated air sampling devices.
    2. Measure particulate levels at multiple points in the production area, including at various heights and near critical equipment to assess the environment properly.
    3. Record the measured levels at regular intervals (e.g., every 30 minutes or as specified in the BMR) to ensure continuous monitoring during production.
    4. Ensure that particulate levels do not exceed the acceptable range as specified in the product specifications or the BMR. The typical limit for airborne particulates should not exceed 3 microns in size (class 1000 cleanroom standard) or other specifications as required by the product.
    5. Immediately notify the production team and QC team if the particulate levels exceed the acceptable limits and take corrective action, such as halting production or adjusting ventilation systems.

    5.3 Handling Deviations

    1. If airborne particulates exceed the acceptable limits, stop the production process immediately to prevent contamination of the cream batch.
    2. Investigate potential causes of the deviation, such as malfunctioning ventilation, improper cleaning, or contamination from materials or equipment.
    3. Implement corrective actions to address the root cause, including cleaning the area, adjusting ventilation systems, or reworking equipment if necessary.
    4. Once the cause of the deviation is addressed, resume production, ensuring that the particulate levels are continuously monitored and remain within specification.
    5. Document the deviation, corrective actions taken, and final results in the Deviation Report (Annexure-1), and ensure that the report is reviewed and signed by the QC team and Laboratory Supervisor.

    5.4 Post-Monitoring Activities

    1. After the production process, ensure that all monitoring data is recorded and reviewed for accuracy. If the particulate levels were within the acceptable range, approve the batch for the next stage (e.g., filling or packaging).
    2. Ensure that all equipment is cleaned, sanitized, and properly stored after the monitoring process.
    3. Review all monitoring records and ensure compliance with GMP and internal cleanliness standards.

    5.5 Documentation and Record-Keeping

    1. Document all particulate measurements in the Airborne Particulate Monitoring Log (Annexure-2). Ensure that the log includes the time, location, particulate levels, and operator details for each reading.
    2. Document any deviations and corrective actions taken in the Deviation Report (Annexure-1), ensuring that all necessary details are captured and signed by the relevant personnel.
    3. Ensure that all records are reviewed by the QC team and signed by the operator performing the monitoring. Store all records for a minimum of two years or as required by regulatory guidelines for traceability and compliance.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • PPE: Personal Protective Equipment
    • μm: Micrometer (unit of particulate size)

    7. Documents

    1. Annexure-1: Deviation Report
    2. Annexure-2: Airborne Particulate Monitoring Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Airborne Particulate Control in Pharmaceutical Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report

    Batch Number Deviation Description Corrective Action Resolved By
    12345 Particulate levels exceeded acceptable range Re-adjusted ventilation settings Michael Lee

    Annexure-2: Airborne Particulate Monitoring Log

    Batch Number Time Particulate Level (μm) Operator Remarks
    12345 09:00 AM 2.5 μm John Doe Within specification
    12345 12:00 PM 2.8 μm Jane Smith Within specification
    12345 03:00 PM 3.2 μm Michael Lee Exceeded limit, corrective action taken

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for High-Shear Mixing in Cream Manufacturing - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: BA-BE Studies: SOP for Auto-sampler Stability of Samples – V 2.0
    Next Post: Elixir Department: SOP for Visual Inspection of Prepared Elixirs – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version